Live Analyst Rating Changes 33545 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Daniel Arias
STIF

Daniel Arias

Stifel Nicolaus
Wall Street Analyst
★★★★★
#47
on 13Foresight · ranked by our own returns
74%
Success Rate
+13.7%
Average Return
42 of 57 calls profitable · +11.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 74% of Daniel Arias's ratings turned a profit when each position was held for 1 year — averaging +13.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

74 Buy 33 Hold 0 Sell
Daniel's Stock Coverage 24 ratings · 2026-09-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TMO
Thermo Fisher
 Sep 15, 2026 BUY Strong Buy
-6.8% avg upside
40 analysts
 — +1.6% ·
RGEN
Repligen
 Sep 15, 2026 BUY Strong Buy
-4.1% avg upside
25 analysts
 — +1.2% ·
ILMN
Illumina
 Sep 15, 2026 BUY Buy
-25.1% avg upside
31 analysts
$225.00
7.85% Downside
 +7.4% ·
A
Agilent
 Aug 30, 2026 BUY Strong Buy
-10.0% avg upside
34 analysts
$180.00
12.03% Upside
 -4.4% ·
MXCT
MaxCyte
 Aug 13, 2026 BUY Buy
+234.8% avg upside
5 analysts
$4.00
234.76% Upside
 -14.4% ·
MASS
908 Devices
 Aug 12, 2026 BUY Strong Buy
+15.7% avg upside
5 analysts
$12.00
13.08% Upside
 +8.5% ·
QGEN
Qiagen
 Aug 11, 2026 HOLD Buy
-3.6% avg upside
24 analysts
$40.00
9.82% Downside
 +1.6% ·
ALMR
Alamar Biosciences, Inc.
 Aug 11, 2026 BUY Strong Buy
-4.2% avg upside
5 analysts
$32.00
7.51% Downside
 -4.7% ·
MRVI
Maravai Lifesciences Holdings
 Aug 11, 2026 BUY Strong Buy
+114.2% avg upside
17 analysts
$8.00
12.67% Upside
 +23.4% ·
TXG
10x Genomics
 Aug 11, 2026 BUY Buy
-42.7% avg upside
18 analysts
$50.00
36.74% Downside
 +35.3% ·
RPID
Rapid Micro Biosystems
 Aug 10, 2026 BUY Strong Buy
+673.0% avg upside
6 analysts
$8.00
598.71% Upside
 -34.5% ·
BLLN
BillionToOne, Inc. Class A
 Aug 06, 2026 BUY Strong Buy
+16.7% avg upside
10 analysts
$145.00
38.15% Upside
 +13.3% ·
WAT
Waters
 Aug 05, 2026 HOLD Strong Buy
-5.6% avg upside
31 analysts
$420.00
0.75% Downside
 +5.4% ·
RVTY
Revvity
 Aug 05, 2026 HOLD Buy
-19.8% avg upside
23 analysts
$110.00
23.41% Downside
 +24.8% ·
BRKR
Bruker
 Aug 05, 2026 HOLD Buy
-7.6% avg upside
22 analysts
$50.00
19.90% Downside
 +17.0% ·
MTD
Mettler-Toledo
 Aug 03, 2026 BUY Buy
-13.5% avg upside
19 analysts
$1600.00
12.14% Upside
 -4.6% ·
TEM
Tempus AI, Inc. Class A
 Aug 03, 2026 HOLD Strong Buy
-12.8% avg upside
23 analysts
$50.00
35.49% Downside
 +69.5% ·
GH
Guardant Health
 Aug 03, 2026 BUY Strong Buy
-4.1% avg upside
32 analysts
$180.00
2.37% Upside
 +9.5% ·
AVTR
Avantor
 Jul 30, 2026 HOLD Buy
+4.5% avg upside
26 analysts
$15.00
1.77% Downside
 +12.0% ·
DHR
Danaher
 Jul 22, 2026 BUY Strong Buy
-1.2% avg upside
46 analysts
$220.00
2.76% Upside
 +18.2% ·
TECH
Bio-Techne
 May 07, 2026 HOLD Buy
+15.1% avg upside
21 analysts
$50.00
31.10% Downside
 +42.5% ·
CDXS
Codexis
 Nov 10, 2025 BUY Strong Buy
+627.7% avg upside
13 analysts
$5.00
259.62% Upside
 -22.3% ·
ABSI
AbSci
 Jan 22, 2025 HOLD Strong Buy
+28.1% avg upside
19 analysts
 — -21.6% ·
RNLXY
Renalytix
 Mar 01, 2024 BUY Strong Buy
+159.1% avg upside
5 analysts
$5.00
20.52% Upside
 · ·
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Daniel Arias — Frequently Asked Questions
How accurate are Daniel Arias's stock ratings?
Based on the calls 13Foresight could measure, about 74% of Daniel's ratings were profitable over a one-year hold, with an average return of +13.7% per rating, or +11.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Daniel ranked on 13Foresight?
Daniel Arias is currently ranked #47 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Daniel cover?
Daniel most recently has ratings on TMO, RGEN, ILMN, A, MXCT, MASS, QGEN, ALMR, MRVI, TXG, RPID, BLLN and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.